DEVELOPMENT AND EVALUATION OF SELF EMULSIFIED DRUG DELIVERY SYSTEM OF EMBELIN FOR THE TREATMENT OF AMOEBIASIS

BHARAT LAL; MANOJ GADEWAR; ARUN GARG

doi:10.22159/ijap.2022v14i3.44222

Authors

BHARAT LAL Department of Pharmaceutics, K. R. Mangalam University, Haryana, India
MANOJ GADEWAR Department of Pharmacology, K. R. Mangalam University, Haryana, India https://orcid.org/0000-0002-0787-6916
ARUN GARG Department of Pharmacology, K. R. Mangalam University, Haryana, India

DOI:

https://doi.org/10.22159/ijap.2022v14i3.44222

Keywords:

Self emulsifying powder, Solubility, Ternary phase diagram, Amoebiasis, Embelin

Abstract

Objective: Development and evaluation of self-emulsified drug delivery system of embelin for the treatment of amoebiasis.

Methods: Self-emulsifying drug delivery systems (SEDDS) were prepared by determining the saturation solubility of embelin in different oil, surfactant and co-surfactant. Pseudo-ternary phase diagram was prepared by using chemix software for the selection of surfactant and co-surfactant ratio, and was optimized as 2:1 (Surfactant: Co-surfactant) for SEDDS. The drug was dissolved in surfactant, followed by the addition of co-surfactant and oil in a beaker. The resultant mixtures were stirred continuously by magnetic stirrer and heated at 40 °C to obtain a homogenous mixture. The prepared drug-loaded SEDD formulation was optimized on the basis of emulsification time, size, PDI, zeta potential and precipitation of drugs. Then the anti-amoebic activity of embelin and metronidazole-loaded SEDDS powder was carried out using microplate reader.

Results: The optimum solubility of embelin was calculated in Capmul MCM EP as oil (37 mg/ml), Kolliphor hs 15 as surfactant (150 mg/ml) and PEG 400 as co-surfactant (19 mg/ml). The formulation F7 i.e. 70% Smix and 30% oil was estimated as optimized formulation. The different values of emblein loaded SEDDS was found to be dilution test (no sign of precipitation), centrifugation test (no sign of phase separation), globule size (Dia 217.5 nm) and PDI (108), zeta potential determination (-31.60 mV), viscosity (17.12 cps) and Eosin red confirmed the o/w type of emulsion. Moreover, the angle of repose SEDDS prepared by using Avicel 200 was found to be Θ=27.474, means flow of powder is good with drug loading capacity of 92.7 %. SEM image and in vitro drug release indicated the 99.3% drug was released from the SEDDS in 120 min. Cytotoxicity study (MTT assay) shows the Plain Drug Suspension, Embelin loaded SEDDS powder and Metronidazole exhibited 100% viability at the concentration range of 1.56-100 mmol. The anti-amoebic IC₅₀values of embelin, metronidazole and embelin loaded SEDDS powder was found 1.519 µmol, 1.354 µmol, 1.84 µmol and 1.35 µmol, respectively.

Conclusion: Present study showed the stronger amoebicidal action of embelin may associated with some specific interaction of the active embelin with the cell wall of the parasites or with a more effective mechanism of penetration into the parasites through membrane channels.

Downloads

Download data is not yet available.

References

Sehgal D, Bhattacharya A, Bhattacharya S. Pathogenesis of infection by Entamoeba histolytica. J Biosci. 1996;21(3):423-32. doi: 10.1007/BF02703099.

Patel PA, Chaulang GM, Akolkotkar A. Self-emulsifying drug delivery system: a review. Res J Pharm Technol. 2008;1:313-23.

Anon, National Medicinal Plants Board. Ministry of Health and Family Welfare press releases; 2008. p. 2-5.

Bhandari U, Ansari MN, Islam F, Tripathi CD. The effect of aqueous extract of Embelia ribes Burm on serum homocysteine, lipids and oxidative enzymes in methionine-induced hyperhomocysteinemia. Indian J Pharmacol. 2008;40(4):152-7. doi: 10.4103/0253-7613.43161, PMID 20040948.

Kallakunta VR, Bandari S, Jukanti Raju, Veerareddy PR. Oral self-emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Technol. 2012;221:375-82. doi: 10.1016/j.powtec.2012.01.032.

Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-micro emulsifying drug delivery systems. Eur J Pharm Sci. 2000;11Suppl 2:S93-8. doi: 10.1016/s0928-0987(00)00167-6, PMID 11033431.

Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nano emulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm. 2009;380(1-2):133-41. doi: 10.1016/j.ijpharm.2009.07.015, PMID 19635537.

Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci. 2008;35(3):183-92. doi: 10.1016/j.ejps.2008.06.013, PMID 18652892.

Yang SC, Gursoy RN, Lambert G, Benita S. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm Res. 2004;21(2):261-70. doi: 10.1023/b:pham.0000016238.44452.f1, PMID 15032307.

Wright CW, O’Neill MJ, Phillipson JD, Warhurst DC. Use of microdilution to assess in vitro antiamoebic activities of Brucea javanica fruits, Simarouba amara stem, and a number of quassinoids. Antimicrob Agents Chemother. 1988;32(11):1725-9. doi: 10.1128/AAC.32.11.1725. PMID 2908094.

Hayat F, Salahuddin A, Zargan J, Azam A. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives). Eur J Med Chem. 2010;45(12):6127-34. doi: 10.1016/j.ejmech.2010.09.066, PMID 20961670.

Guo F, Zhong H, He J, Xie B, Liu F, Xu H, Liu M, Xu C. Self-micro emulsifying drug delivery system for improved oral bioavailability of dipyridamole: preparation and evaluation. Arch Pharm Res. 2011;34(7):1113-23. doi: 10.1007/s12272-011-0709-8, PMID 21811918.

Dineshchandra SK, Dixit PC. Sem and D. Joshi, An experiment study of kutajarishta with special reference to amoebiasis. Anc Sci Life. 1988;VIII:100-2.

Guerrant RL, Brush J, Ravdin JI, Sullivan JA, Mandell GL. Interaction between Entamoeba histolytica and human polymorphonuclear neutrophils. J Infect Dis. 1981;143(1):83-93. doi: 10.1093/infdis/143.1.83, PMID 6260869.

Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179-88. doi: 10.1016/s0939-6411(00) 00089-8, PMID 10840200.

Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm. 2007;57(1):111-22. doi: 10.2478/v10007-007-0009-5. PMID 19839411.

Bowte WJ. Materials, process and manufacturing considerations for lipid based hard capsules formats. Oral lipid-based formulations-enhancing the bioavailability of poorly water soluble drugs. Hauss DJ. 2007;170:13-39.

Pittman FE, Hennigar GR. Sigmoidoscopic and colonic mucosal biopsy findings in amebic colitis. Arch Pathol. 1974;97(3):155-8. PMID 4130018.